Kimball Electronics (KE) Company presentation summary
Event summary combining transcript, slides, and related documents.
Company presentation summary
20 Mar, 2026Company overview and strategic positioning
Global provider of electronics manufacturing and contract manufacturing services with a diversified portfolio in automotive, medical, and industrial markets, supported by long program life cycles.
Specializes in high-complexity, non-commodity manufacturing requiring advanced engineering and reliability.
Operates 7 manufacturing locations across North America, Europe, and Asia, with over 5,500 employees and $1.49B in FY25 revenue.
Core values emphasize customer focus, people, environmental citizenship, and profit as a measure of efficiency.
Integrated service platform and capabilities
Offers end-to-end services: design, prototyping, new product introduction, manufacturing, testing, and aftermarket support.
EMS includes PCB assembly, system assembly, prototyping, supply chain management, and design engineering.
CMO focuses on medical solutions, including scientific injection molding, cold chain management, and complex device assembly.
Market verticals and customer base
Revenue split in FY25: 49% automotive, 27% medical, 24% industrial.
Automotive growth driven by vehicle electrification and electronic content; key customers include Tier 1 suppliers.
Medical segment supports the continuum of care, focusing on Class II and III devices for leading healthcare brands.
Industrial segment targets clean energy, automation, and public safety, with diversification into new sub-verticals.
Latest events from Kimball Electronics
- Medical segment growth and facility expansion drive strategic shift and margin improvement.KE
2026 KeyBanc Capital Markets Healthcare Forum19 Mar 2026 - Q2 sales fell 5% but margins and 2026 guidance improved on strong medical growth.KE
Q2 20265 Feb 2026 - Q4 sales dropped 13% as inventory and liquidity improved; 2025 outlook remains cautious.KE
Q4 20241 Feb 2026 - Streamlined operations and global focus drive resilience despite EMS market headwinds.KE
The Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - FY 2025 sales expected to decline 8–14% as focus shifts to automation, medical, and debt reduction.KE
2024 Annual Gateway Conference22 Jan 2026 - Q1 sales fell 15% as restructuring, divestitures, and strong cash flow drove debt reduction.KE
Q1 202516 Jan 2026 - Strategic medical CMO expansion and operational discipline set the stage for future growth.KE
The Gateway Conference 20255 Jan 2026 - Q2 FY25 net sales fell 15% year-over-year, but liquidity and balance sheet improved.KE
Q2 202523 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and ESG progress amid strong governance.KE
Proxy Filing1 Dec 2025